The hope is that pathophysiological research will yield more effective treatments. From this perspective, unique subgroups may exhibit unique dysfunctions in neural circuits that respond to specific treatments targeting these dysfunctions. Modest effectiveness in treating a heterogeneous construct such as conduct disorder may reflect the failure to tailor treatments to specific pathogenic mechanisms.
